gadolinium has been researched along with Prostatic Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asbach, P; Hamm, B; Lee, CH; Taupitz, M; Vellayappan, B | 1 |
| Schnall, MD; Siegelman, ES | 1 |
| Gevenois, PA; Salmon, I; Simon, J; Sintzoff, SA; Stallenberg, B; Struyven, J; Van Regemorter, G | 1 |
1 review(s) available for gadolinium and Prostatic Diseases
| Article | Year |
|---|---|
Contrast-enhanced MR imaging of the bladder and prostate.
Topics: Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Prostate; Prostatic Diseases; Prostatic Neoplasms; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1996 |
1 trial(s) available for gadolinium and Prostatic Diseases
| Article | Year |
|---|---|
Gadolinium-DOTA enhanced MR imaging of prostatic lesions. Preliminary results on 14 cases.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis | 1992 |
1 other study(ies) available for gadolinium and Prostatic Diseases
| Article | Year |
|---|---|
Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
Topics: Aged; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostate; Prostatic Diseases; Reproducibility of Results; Retrospective Studies | 2019 |